Pure Pharm Peptides

Pure Pharm Peptides

Research Supplier

Age Verification Required

This website sells research-grade compounds intended for laboratory use only.

You must be 21 years of age or older to access this site.

For Research Use Only

Not for Human Consumption

By entering, you confirm you are 21+ and agree to our Terms of Service.

🏀🏀🏀🏀🏀🏀🏀🏀

🏀 March Madness Special 🏀  20% Off Every Order in March   🏀  No code needed — applied at checkout!  🏀

Cognitive Research2026-03-029 min read

Neurotrophin Signaling: How Peptides May Support BDNF and NGF

Research Use Only. This article is for scientific and educational reference only. All products are sold for research purposes and are not intended for human or animal consumption.

# Neurotrophin Signaling: How Peptides May Support BDNF and NGF

For Research Purposes Only -- Not Intended for Human or Animal Consumption

Introduction

Neurotrophins are a family of proteins that support the survival, development, and function of neurons. They are essential for neuroplasticity -- the brain's ability to form new connections and adapt to experience. Age-related decline in neurotrophin levels is associated with cognitive decline, depression, and neurodegenerative disease. Several research peptides have documented effects on neurotrophin expression, making this pathway a key target for cognitive and neuroprotective research.

The Neurotrophin Family

Four neurotrophins have been identified in mammals:

BDNF (Brain-Derived Neurotrophic Factor): The most abundant neurotrophin in the adult brain. BDNF supports hippocampal neurogenesis, synaptic plasticity (long-term potentiation), and neuronal survival. It is the primary mediator of exercise-induced cognitive benefits and is reduced in depression, Alzheimer's disease, and aging.

NGF (Nerve Growth Factor): The first neurotrophin discovered (Levi-Montalcini, Nobel Prize 1986). NGF is essential for the survival of cholinergic neurons in the basal forebrain -- the neurons most affected in Alzheimer's disease. It also supports peripheral sensory and sympathetic neurons.

NT-3 (Neurotrophin-3): Supports proprioceptive neurons and is involved in motor function and coordination.

NT-4/5 (Neurotrophin-4/5): Supports motor neurons and some sensory neurons.

Neurotrophin Receptors

Neurotrophins signal through two receptor types:

Trk receptors (Tropomyosin receptor kinases): High-affinity receptors that mediate the survival and plasticity-promoting effects of neurotrophins: - TrkA: Preferentially binds NGF - TrkB: Preferentially binds BDNF and NT-4/5 - TrkC: Preferentially binds NT-3

Trk receptor activation triggers PI3K/Akt (survival), MAPK/ERK (differentiation), and PLCgamma (synaptic plasticity) signaling cascades.

p75NTR (p75 neurotrophin receptor): A low-affinity receptor that binds all neurotrophins. Depending on context, p75NTR can promote either neuronal survival (when co-expressed with Trk receptors) or apoptosis (in the absence of Trk receptors).

BDNF and Synaptic Plasticity

BDNF is the neurotrophin most directly relevant to learning and memory. Its role in synaptic plasticity is well-established:

Long-term potentiation (LTP): BDNF is required for the late phase of LTP -- the sustained synaptic strengthening that underlies long-term memory formation. BDNF activates TrkB, which promotes the insertion of AMPA receptors into the synapse and the structural remodeling of dendritic spines.

Hippocampal neurogenesis: BDNF promotes the survival and integration of newly born neurons in the hippocampal dentate gyrus. Adult hippocampal neurogenesis is associated with learning and memory performance and is reduced by stress, aging, and depression.

BDNF-memory hypothesis: Reduced BDNF levels are associated with cognitive decline in aging and Alzheimer's disease. Interventions that increase BDNF (exercise, antidepressants, caloric restriction) are associated with improved cognitive function.

Peptides and Neurotrophin Upregulation

Semax: The best-characterized peptide for BDNF upregulation. Dolotov et al. (2006) demonstrated that intranasal Semax administration increased BDNF mRNA and protein levels in rat hippocampus within hours. The mechanism involves melanocortin receptor activation (MC4R) and downstream CREB activation, which drives BDNF gene transcription.

Selank: Also upregulates BDNF in the hippocampus, through a mechanism that may involve GABAergic modulation and downstream effects on CREB. The combination of Semax + Selank may produce additive BDNF upregulation through complementary mechanisms.

BPC-157: Has been shown to upregulate BDNF in the hippocampus in some animal models, particularly in stress and injury conditions. The mechanism may involve its effects on the gut-brain axis -- gut microbiome composition and enteric nervous system function influence hippocampal BDNF levels through vagal and hormonal pathways.

NGF and Cholinergic Neuron Support

NGF is particularly relevant to Alzheimer's disease research because basal forebrain cholinergic neurons (BFCNs) -- which project to the hippocampus and cortex and are essential for memory -- are NGF-dependent. BFCN degeneration in Alzheimer's disease correlates with cognitive decline and is associated with reduced NGF signaling.

Research into NGF-supporting peptides is therefore relevant to Alzheimer's disease models. Some peptides have been studied for effects on NGF expression, though this area is less developed than the BDNF literature.

References

  1. Dolotov, O.V., et al. (2006). Semax regulates BDNF and trkB expression in the rat hippocampus. Brain Research, 1117(1), 54-60.
  2. Bhattacharya, T.K., et al. (2015). Mind and movement: exercise and neurogenesis. Exercise and Sport Sciences Reviews, 43(4), 201-207.
  3. Levi-Montalcini, R. (1987). The nerve growth factor 35 years later. Science, 237(4819), 1154-1162.

Research Grade Available

All compounds referenced in this article are available as research-grade peptides, independently verified by Freedom Diagnostics.